Clinical Trial Update: Assessment of the Efficacy of Scorpion Antivenom Therapy in a Dose-response Manner, in Patients With Scorpionism [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating the dose-response efficacy of scorpion antivenom in scorpion envenomation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Scorpion Envenomation

Drugs mentioned

• Scorpion Antivenom (antivenom)

Snippet

Sponsor: Selene Guadalupe Huerta Olvera | Conditions: Centruroides Envenomation | Phase 2, Phase 3 | Status: COMPLETED